Express Scripts Holding Company (NASDAQ: ESRX) Stock Competitors & Peer Comparison
See ESRX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ESRX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ESRX | $92.33 | +0.00% | 0 | 10.69 | $8.64 | N/A |
| RPRX | $66.52 | -0.98% | 29.6B | 12.67 | $5.25 | +1.38% |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| CORT | $80.46 | -0.81% | 8.7B | 229.89 | $0.35 | N/A |
| KNSA | $90.80 | -1.56% | 7.1B | 69.77 | $1.30 | N/A |
| LQDA | $41.85 | -7.12% | 3.7B | 30.55 | $1.37 | N/A |
| PBH | $49.73 | +1.37% | 2.4B | 11.26 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $13.51 | -3.15% | 811.5M | -5.35 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
ESRX vs RPRX Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, RPRX has a market cap of 29.6B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while RPRX trades at $66.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas RPRX's P/E ratio is 12.67. In terms of profitability, ESRX's ROE is +0.26%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, ESRX is less volatile compared to RPRX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check RPRX's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
ESRX vs WBA Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas WBA's P/E ratio is -1.64. In terms of profitability, ESRX's ROE is +0.26%, compared to WBA's ROE of -0.57%. Regarding short-term risk, ESRX is similarly volatile compared to WBA. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check WBA's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
ESRX vs CORT Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CORT has a market cap of 8.7B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CORT trades at $80.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CORT's P/E ratio is 229.89. In terms of profitability, ESRX's ROE is +0.26%, compared to CORT's ROE of +0.08%. Regarding short-term risk, ESRX is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CORT's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
ESRX vs KNSA Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, KNSA has a market cap of 7.1B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while KNSA trades at $90.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas KNSA's P/E ratio is 69.77. In terms of profitability, ESRX's ROE is +0.26%, compared to KNSA's ROE of +0.17%. Regarding short-term risk, ESRX is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
ESRX vs LQDA Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, LQDA has a market cap of 3.7B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while LQDA trades at $41.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas LQDA's P/E ratio is 30.55. In terms of profitability, ESRX's ROE is +0.26%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, ESRX is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
ESRX vs PBH Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while PBH trades at $49.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas PBH's P/E ratio is 11.26. In terms of profitability, ESRX's ROE is +0.26%, compared to PBH's ROE of +0.09%. Regarding short-term risk, ESRX is less volatile compared to PBH. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
ESRX vs HROWL Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas HROWL's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, ESRX is less volatile compared to HROWL. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
ESRX vs HROWM Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas HROWM's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, ESRX is less volatile compared to HROWM. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
ESRX vs LTGO Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, LTGO has a market cap of 811.5M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while LTGO trades at $13.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas LTGO's P/E ratio is -5.35. In terms of profitability, ESRX's ROE is +0.26%, compared to LTGO's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
ESRX vs HELP Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, HELP has a market cap of 545.5M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while HELP trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas HELP's P/E ratio is -2.11. In terms of profitability, ESRX's ROE is +0.26%, compared to HELP's ROE of -0.71%. Regarding short-term risk, ESRX is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
ESRX vs SVA Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SVA's P/E ratio is -5.68. In terms of profitability, ESRX's ROE is +0.26%, compared to SVA's ROE of -0.01%. Regarding short-term risk, ESRX is similarly volatile compared to SVA. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
ESRX vs CUVL Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CUVL has a market cap of 249.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CUVL trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CUVL's P/E ratio is 10.68. In terms of profitability, ESRX's ROE is +0.26%, compared to CUVL's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CUVL's competition here
High Tide Inc. (NASDAQ: HITI)
ESRX vs HITI Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, HITI has a market cap of 230.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while HITI trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas HITI's P/E ratio is -9.57. In terms of profitability, ESRX's ROE is +0.26%, compared to HITI's ROE of -0.36%. Regarding short-term risk, ESRX is less volatile compared to HITI. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check HITI's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
ESRX vs CELG-RI Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CELG-RI has a market cap of 194.1M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CELG-RI trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, ESRX is similarly volatile compared to CELG-RI. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check CELG-RI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
ESRX vs ETRA Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, ETRA has a market cap of 155.1M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while ETRA trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas ETRA's P/E ratio is -2.76. In terms of profitability, ESRX's ROE is +0.26%, compared to ETRA's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
ESRX vs TRXB Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, TRXB has a market cap of 114.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while TRXB trades at $13.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas TRXB's P/E ratio is -5.56. In terms of profitability, ESRX's ROE is +0.26%, compared to TRXB's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to TRXB. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check TRXB's competition here
Atlantic International Corp. (NASDAQ: ATLN)
ESRX vs ATLN Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas ATLN's P/E ratio is -0.68. In terms of profitability, ESRX's ROE is +0.26%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, ESRX is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
ESRX vs CTOR Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CTOR has a market cap of 55.2M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CTOR trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CTOR's P/E ratio is -1.26. In terms of profitability, ESRX's ROE is +0.26%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, ESRX is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CTOR's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
ESRX vs RTSN Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, RTSN has a market cap of 43.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while RTSN trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas RTSN's P/E ratio is -4.45. In terms of profitability, ESRX's ROE is +0.26%, compared to RTSN's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to RTSN. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
ESRX vs RAD Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas RAD's P/E ratio is -0.05. In terms of profitability, ESRX's ROE is +0.26%, compared to RAD's ROE of +2.76%. Regarding short-term risk, ESRX is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
ESRX vs GLTO Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas GLTO's P/E ratio is -1.78. In terms of profitability, ESRX's ROE is +0.26%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, ESRX is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check GLTO's competition here
Cosmos Health Inc. (NASDAQ: COSM)
ESRX vs COSM Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, COSM has a market cap of 31.1M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while COSM trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas COSM's P/E ratio is -0.42. In terms of profitability, ESRX's ROE is +0.26%, compared to COSM's ROE of -1.19%. Regarding short-term risk, ESRX is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check COSM's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
ESRX vs NSRX Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, NSRX has a market cap of 27.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while NSRX trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas NSRX's P/E ratio is -4.44. In terms of profitability, ESRX's ROE is +0.26%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, ESRX is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
ESRX vs SCYX Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SCYX has a market cap of 24M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SCYX trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SCYX's P/E ratio is -1.11. In terms of profitability, ESRX's ROE is +0.26%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, ESRX is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check SCYX's competition here
Pomdoctor Limited (NASDAQ: POM)
ESRX vs POM Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, POM has a market cap of 16.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while POM trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas POM's P/E ratio is -0.28. In terms of profitability, ESRX's ROE is +0.26%, compared to POM's ROE of +0.80%. Regarding short-term risk, ESRX is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check POM's competition here
Biofrontera Inc. (NASDAQ: BFRI)
ESRX vs BFRI Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, BFRI has a market cap of 13M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while BFRI trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas BFRI's P/E ratio is -1.59. In terms of profitability, ESRX's ROE is +0.26%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, ESRX is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check BFRI's competition here
Cerenome, Inc. (NASDAQ: CNSY)
ESRX vs CNSY Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CNSY has a market cap of 12.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CNSY trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CNSY's P/E ratio is -0.41. In terms of profitability, ESRX's ROE is +0.26%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, ESRX is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CNSY's competition here
Azora Therapeutics, Inc. (NASDAQ: AZR)
ESRX vs AZR Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, AZR has a market cap of 10.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while AZR trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas AZR's P/E ratio is -0.24. In terms of profitability, ESRX's ROE is +0.26%, compared to AZR's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to AZR. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check AZR's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
ESRX vs CJJD Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CJJD's P/E ratio is -0.46. In terms of profitability, ESRX's ROE is +0.26%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, ESRX is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
ESRX vs SSY Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SSY's P/E ratio is -2.86. In terms of profitability, ESRX's ROE is +0.26%, compared to SSY's ROE of -0.09%. Regarding short-term risk, ESRX is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
ESRX vs SCNX Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SCNX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SCNX's P/E ratio is -1.54. In terms of profitability, ESRX's ROE is +0.26%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, ESRX is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
ESRX vs BGMS Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, BGMS has a market cap of 5M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas BGMS's P/E ratio is -0.25. In terms of profitability, ESRX's ROE is +0.26%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, ESRX is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check BGMS's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
ESRX vs MDVL Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas MDVL's P/E ratio is -0.05. In terms of profitability, ESRX's ROE is +0.26%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, ESRX is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check MDVL's competition here
Eocene Ltd. (NASDAQ: EOCN)
ESRX vs EOCN Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, EOCN has a market cap of 2.8M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while EOCN trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas EOCN's P/E ratio is -0.19. In terms of profitability, ESRX's ROE is +0.26%, compared to EOCN's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to EOCN. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check EOCN's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
ESRX vs PAVS Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, PAVS has a market cap of 2.7M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while PAVS trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas PAVS's P/E ratio is -0.03. In terms of profitability, ESRX's ROE is +0.26%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, ESRX is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
ESRX vs ATNFW Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas ATNFW's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, ESRX is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
ESRX vs BGMSP Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, ESRX's ROE is +0.26%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, ESRX is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
ESRX vs AZNH Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas AZNH's P/E ratio is 38.35. In terms of profitability, ESRX's ROE is +0.26%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, ESRX is less volatile compared to AZNH. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check AZNH's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP)
ESRX vs ASBP Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, ASBP has a market cap of 842.2K. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while ASBP trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas ASBP's P/E ratio is -0.31. In terms of profitability, ESRX's ROE is +0.26%, compared to ASBP's ROE of +19.93%. Regarding short-term risk, ESRX is less volatile compared to ASBP. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check ASBP's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
ESRX vs BFRIW Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, BFRIW has a market cap of 796.7K. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while BFRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas BFRIW's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, ESRX is similarly volatile compared to BFRIW. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check BFRIW's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
ESRX vs LFLYW Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, ESRX's ROE is +0.26%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, ESRX is similarly volatile compared to LFLYW. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check LFLYW's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBPW)
ESRX vs ASBPW Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, ASBPW has a market cap of 149.5K. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while ASBPW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas ASBPW's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to ASBPW's ROE of +19.93%. Regarding short-term risk, ESRX is less volatile compared to ASBPW. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check ASBPW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
ESRX vs PRPH Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, PRPH has a market cap of 91.1K. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas PRPH's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, ESRX is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check PRPH's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
ESRX vs IPXL Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, IPXL has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas IPXL's P/E ratio is -10.11. In terms of profitability, ESRX's ROE is +0.26%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, ESRX is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check IPXL's competition here
POZEN Inc. (NASDAQ: POZN)
ESRX vs POZN Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, POZN has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas POZN's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to POZN's ROE of +0.61%. Regarding short-term risk, ESRX is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check POZN's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
ESRX vs CPD Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CPD has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CPD's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to CPD's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to CPD. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CPD's competition here
Shire plc (NASDAQ: SHPG)
ESRX vs SHPG Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SHPG has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SHPG's P/E ratio is 11.35. In terms of profitability, ESRX's ROE is +0.26%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, ESRX is similarly volatile compared to SHPG. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check SHPG's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
ESRX vs OREX Comparison November 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, OREX has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas OREX's P/E ratio is -0.14. In terms of profitability, ESRX's ROE is +0.26%, compared to OREX's ROE of -0.54%. Regarding short-term risk, ESRX is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check OREX's competition here